NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2018
- Summary of accounting policies
- Critical accounting estimates and assumptions
- Financial risk management
- Business combinations
- Segment information
- Property, equipment and investment property
- Intangible assets
- Financial instruments
- Investment in associates
- Investment in subsidiaries
- Deferred income tax
- Inventory
- Issued share capital
- Other reserves
- Non-controlling interest
- Accrual for straight-lining of leases
- Employment benefit liability
- Revenue
- Cost of pharmaceutical products and finished goods
- Profit before taxation
- Net finance costs
- Income tax expense
- Earnings per share
- Cash generated from operations
- Taxation paid
- Dividends
- Share-based payments
- Contingencies, commitments and guarantees
- Related party transactions
- Pensions and other retirement obligations
- Contingent consideration
- Deferred payment
- Subsequent events